Article: New Study Minimizes Concerns about PGD's Impact on Embryos and Offers Encouraging Data on Implantation Success Rates; Lawrence Werlin Presents New Study at Pacific Coast Reproductive Society's Annual Conference.

IRVINE, Calif. -- At the Pacific Coast Reproductive Society's (PCRS) Annual Conference, Dr. Lawrence B. Werlin will present groundbreaking discoveries from his research on the effects of Preimplantation Genetic Diagnosis (PGD) on embryos. The conference, May 4-8, 2005, in Indian Wells, Calif., brings together leaders in the field of reproductive medicine throughout North America and abroad.

PGD is a therapeutic and genetic testing tool that allows for the analysis and transfer of healthy embryos back to the uterus. Over the years, PGD has gained greater recognition for its ability to analyze the cells of a developing embryo via biopsy for genetic and chromosomal ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!